Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macro-metastatic nodes: EADO trial

Grob, J. J. and Jouary, T. and Dreno, B. and Gutzmer, R. and Hauschild, A. and Leccia, M. T. and Landthaler, M. and Asselineau, J. and Garbe, C. and Pehamberger, H. E. (2010) Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macro-metastatic nodes: EADO trial. JOURNAL OF CLINICAL ONCOLOGY, 28 (18supp): LBA8506. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Petra Gürster
Date Deposited: 16 Apr 2020 08:23
Last Modified: 16 Apr 2020 08:23
URI: https://pred.uni-regensburg.de/id/eprint/24552

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.